Urologic Imaging

What Imaging Is Best for Microhematuria Without Risk Factors? An ACR Workflow

·
What Imaging Is Best for Microhematuria Without Risk Factors? An ACR Workflow

A 45-year-old patient presents for an annual physical. They feel well, with no new complaints. As part of a routine screening, a urinalysis is performed and returns positive for microscopic hematuria. The finding is confirmed on a repeat test. The patient has no history of smoking, no family history of urologic malignancy, no occupational exposures, and no symptoms like flank pain or dysuria. You are now faced with the clinical question: does this incidental finding in a low-risk individual warrant an imaging workup, and if so, which study is the right first step? This article provides a detailed workflow for this specific scenario, guided by the American College of Radiology (ACR) Appropriateness Criteria, which rate a CT of the abdomen and pelvis without IV contrast as May be appropriate.

Who Fits This Clinical Scenario for Low-Risk Microhematuria?

This guidance applies to a very specific patient population: adults with asymptomatic microscopic hematuria (defined as three or more red blood cells per high-powered field on a properly collected urine specimen) who have no identifiable risk factors for urothelial cancer. The key is that the hematuria is an isolated, incidental finding.

Inclusion criteria for this workflow are:

  • Asymptomatic microscopic hematuria confirmed on at least two urinalyses.
  • Absence of risk factors for malignancy (e.g., smoking history, occupational chemical exposure, history of pelvic radiation, family history of urothelial cancer or Lynch syndrome).
  • Absence of benign explanatory causes such as recent vigorous exercise, active infection (UTI), viral illness, or menstruation.

It is critical to distinguish this group from others who may present similarly but require a different diagnostic approach. This workflow does not apply if the patient:

  • Has risk factors for malignancy. A patient with a significant smoking history falls into a higher-risk category, warranting a more comprehensive evaluation.
  • Is pregnant. Imaging decisions in pregnancy are highly specialized to avoid radiation exposure to the fetus.
  • Presents with gross hematuria. Visible blood in the urine is a significant finding that always requires a full urologic workup, typically starting with different imaging.

What Diagnoses Are You Working Up in This Low-Risk Scenario?

In a patient with asymptomatic microhematuria and no risk factors, the pre-test probability of a life-threatening condition is low. The imaging workup is primarily aimed at identifying or excluding common, treatable causes while being mindful of the risks of radiation and over-investigation.

Urolithiasis (Kidney Stones): This is the most common structural cause of hematuria across all risk groups. Small, non-obstructing stones in the kidneys or ureters can easily cause microscopic bleeding without causing pain or other symptoms. A non-contrast CT is the gold standard for detecting stones, making this the primary diagnostic target of the recommended imaging study.

Renal Cell Carcinoma (RCC): While a serious consideration, small, early-stage renal cancers are an uncommon cause of isolated microscopic hematuria. Larger masses can be detected on non-contrast CT, but this study is not optimized for characterizing small renal lesions. The goal here is to screen for obvious masses, not to definitively rule out a tiny malignancy.

Urothelial Carcinoma: This is the most significant “can’t-miss” diagnosis in any hematuria workup. However, in this specific low-risk population, the incidence is very low. The recommended imaging (non-contrast CT) is not sensitive for small urothelial tumors of the bladder, ureters, or renal pelvis. The decision to pursue imaging is a balance between detecting stones and the very low likelihood of finding a malignancy that would be missed by other components of the urologic evaluation, such as cystoscopy.

Benign and Idiopathic Causes: Many cases of microhematuria have no identifiable cause after a full workup. Benign conditions like benign prostatic hyperplasia (BPH) in men or anatomical variants can sometimes be implicated. The role of imaging is often to provide reassurance by ruling out significant structural pathology like stones or large masses.

Why Is CT Abdomen and Pelvis Without IV Contrast Rated ‘May Be Appropriate’?

The ACR rating of May be appropriate for a non-contrast CT of the abdomen and pelvis reflects the clinical nuance of this scenario. It is not a strong, universal recommendation but an option to be considered in shared decision-making with the patient. The rationale hinges on balancing the high sensitivity for the most likely finding (stones) against the low probability of malignancy and the risks of radiation.

The primary strength of a non-contrast CT is its exceptional sensitivity and specificity for urolithiasis. It can detect stones of any composition (except for very rare indinavir stones) as small as 1-2 mm anywhere in the urinary tract. Since stones are the most frequent structural cause of hematuria, this makes non-contrast CT a high-yield study for that specific differential diagnosis. The study involves a single, fast acquisition, delivering a moderate radiation dose (ACR Relative Radiation Level ☢☢☢, corresponding to 1-10 mSv) without the risks associated with IV contrast media.

Alternative imaging studies are rated lower for specific reasons in this context:

  • Ultrasound (US) of the kidneys and bladder is rated Usually not appropriate. While it involves no radiation and is excellent for detecting hydronephrosis or large renal masses, it has poor sensitivity for small stones, especially those located in the ureter. A negative ultrasound can be falsely reassuring and may not adequately evaluate for the most common cause of microhematuria, potentially leading to delayed diagnosis or the need for subsequent CT imaging.
  • CT Urography (CTU) without and with IV contrast is also rated Usually not appropriate. CTU is the standard for evaluating high-risk hematuria because its multiple phases are designed to opacify and visualize the entire urothelium. However, in this low-risk scenario, the diagnostic yield for urothelial cancer is extremely low, and the significantly higher radiation dose (ACR RRL ☢☢☢☢, 10-30 mSv) and use of IV contrast are not justified by the pre-test probability.

The decision to order the non-contrast CT should therefore be based on a discussion of these trade-offs. If the primary goal is to definitively rule out stone disease as the cause, it is the best available test. Once you’ve decided on this study, our protocol guide covers the technique, contrast, and reading principles: CT Abdomen/Pelvis Without Contrast (Renal Stone).

What’s Next After CT Abdomen and Pelvis Without IV Contrast? Downstream Workflow

The results of the non-contrast CT will guide the next steps in the patient’s management. The workflow branches based on whether the study is positive, negative, or indeterminate.

If the study is positive for urolithiasis: The patient should be referred to a urologist. Management will depend on the size, location, and number of stones. Small, asymptomatic renal calculi may be managed with observation and hydration, while larger or potentially obstructive stones may require intervention. The finding of stones provides a clear explanation for the microhematuria, and the workup for this specific finding is often complete.

If the study is negative: This is a very common outcome. A negative non-contrast CT effectively rules out clinically significant stone disease and large renal or adrenal masses. However, it does not complete the evaluation for hematuria. The American Urological Association (AUA) guidelines often recommend that patients with persistent asymptomatic microhematuria, even with negative imaging, undergo cystoscopy to directly visualize the bladder lining. A negative CT should not preclude a urology referral if the microhematuria persists on follow-up urinalysis.

If the study is indeterminate: Occasionally, a non-contrast CT may reveal an incidental finding that requires further characterization, such as a small, hyperdense renal cyst or a subtle area of renal parenchymal heterogeneity. This moves the patient out of the low-risk microhematuria pathway and into a different diagnostic algorithm, typically requiring a contrast-enhanced, dedicated imaging study like a renal mass protocol CT or an MRI to further evaluate the finding.

Pitfalls to Avoid (and When to Get Help)

Navigating the workup for low-risk microhematuria requires careful attention to avoid common missteps. Here are a few pitfalls to keep in mind:

  • Misclassifying Patient Risk: The most critical error is failing to identify a risk factor. Always perform a thorough history, specifically asking about smoking (even remote), occupational exposures (paints, dyes, solvents), and family history of urologic cancers. Treating a high-risk patient with this low-risk pathway can delay a cancer diagnosis.
  • Stopping the Workup After a Negative CT: Remember that a non-contrast CT is primarily a “stone hunt.” It is not sensitive for flat urothelial lesions in the bladder or ureters. Persistent microhematuria after a negative CT still warrants consideration for urologic referral and cystoscopy.
  • Ordering a Full CT Urogram by Default: Resist the reflex to order the most comprehensive study (CTU) for every case of hematuria. For this low-risk population, the radiation exposure far outweighs the minimal potential benefit over a non-contrast study combined with clinical follow-up.

If microhematuria persists over several months despite a negative initial workup, or if the patient develops any new symptoms such as flank pain, voiding difficulties, or gross hematuria, prompt referral to a urologist is essential.

Related ACR Topics and Tools

This article focuses on one specific clinical variant. For a comprehensive overview of imaging for all hematuria presentations, from gross hematuria to pediatric cases, please consult our parent guide. You can also use the tools below to explore adjacent scenarios, review imaging protocols, and discuss radiation dose with your patients.

Frequently Asked Questions

Why isn’t ultrasound the first choice for low-risk microhematuria if it has no radiation?

Ultrasound is rated ‘Usually not appropriate’ because its primary limitation is poor sensitivity for kidney and ureteral stones, which are the most common treatable cause of microhematuria. A negative ultrasound can be falsely reassuring, as it may miss the underlying pathology, potentially leading to delayed diagnosis or requiring a follow-up CT scan anyway.

If the non-contrast CT is negative, is the workup for cancer complete?

No. A negative non-contrast CT effectively rules out significant stone disease and large renal masses, but it is not a sensitive test for detecting urothelial carcinoma, especially small or flat tumors in the bladder or ureters. According to urology guidelines, patients with persistent microhematuria often require a cystoscopy to directly visualize the bladder, regardless of negative imaging results.

What specific findings on history would move this patient into a ‘high-risk’ category?

Several factors would classify a patient as high-risk, necessitating a more aggressive workup (typically with CT Urography and cystoscopy). These include a history of smoking, occupational exposure to chemicals or dyes (e.g., in textile, paint, or rubber industries), a personal or family history of urothelial cancer or Lynch syndrome, a history of pelvic radiation, or chronic use of certain medications like cyclophosphamide.

Does a single instance of microhematuria after vigorous exercise require this workup?

No. Transient microhematuria immediately following strenuous activity is a well-documented, benign phenomenon. The standard approach is to have the patient avoid vigorous exercise for 48-72 hours and then repeat the urinalysis. If the hematuria resolves, no further imaging workup is needed for that indication.

At what age does a patient with microhematuria stop being considered ‘low-risk’?

Age itself is a risk factor, with the risk of malignancy increasing significantly after age 50 or 60. However, the ACR and AUA guidelines focus more on the presence or absence of specific risk factors like smoking rather than a single age cutoff. A 65-year-old lifelong non-smoker with no other risk factors may still fit this low-risk pathway, while a 40-year-old smoker would be considered high-risk.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 26, 2026